Where do we stand with targeted therapy of refractory thyroid cancer?--Utility of RECIST criteria.
Pacini
Furio
F
D018263:Adenocarcinoma, Follicular / Q000188:drug therapy* / Q000532:radiotherapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*
D000970:Antineoplastic Agents